Of the several cell markers, including CD133, CD144, and CD166, that have been used to identify CSCs, a number of independent studies have demonstrated that the CD133+ subpopulation of colon cancer cells possess higher levels of stemness and tumorigenicity that the CD133− subpopulation. This evidence concerns the gene PROM1 and malignant colon neoplasm.